<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chemokine receptor 1 (CCR1) is a G protein-coupled receptor that binds to members of the C-C chemokine family </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, CCL3 (MIP-1alpha), a high-affinity CCR1 ligand, was identified as part of a model that independently predicts survival in patients with diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>However, the role of chemokine signaling in the pathogenesis of human <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is unclear </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> human hematopoietic tissues, we found CCR1 expression in intraepithelial B cells of human tonsil and granulocytic/monocytic cells in the bone marrow </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemical analysis of 944 cases of hematolymphoid <z:hpo ids='HP_0002664'>neoplasia</z:hpo> identified CCR1 expression in a subset of B- and T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, plasma cell <z:mp ids='MP_0009440'>myeloma</z:mp>, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, and classical Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>CCR1 expression correlated with the non-germinal center subtype of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> but did not predict overall survival in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>These data suggest that CCR1 may be useful for <z:hpo ids='HP_0002665'>lymphoma</z:hpo> classification and support a role for chemokine signaling in the pathogenesis of hematolymphoid <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>